SynthesisTranslational psychiatry2026
Lithium effects in the frontolimbic circuitry: a systematic review of neuroimaging findings in bipolar disorder.
Synthesis in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLithium is a cornerstone treatment for bipolar disorder, but the biological mechanisms underlying its therapeutic effects remain incompletely defined. We adopt a network-level, cross-modal perspective focused on frontolimbic circuitry and explicitly examine links between neuroimaging findings and clinical lithium response.
methodsFollowing PRISMA guidelines, we searched PubMed and Embase to September 3, 2025. Studies of humans were eligible when they compared lithium-treated bipolar subjects with non-lithium bipolar subjects, other treatment, healthy controls, or within-subject baselines. Risk of bias was assessed with RoB 2, ROBINS-I, NOS/NOS-CS, and BrainNet Europe criteria, as appropriate.
resultsWe included 115 studies (randomized, n = 6; non-randomized, n = 25; observational cohort, n = 2; cross-sectional, n = 78; post-mortem, n = 4). Across modalities, lithium treatment was most consistently associated with larger volumes in the hippocampus, amygdala, anterior cingulate cortex (ACC), and prefrontal cortex (PFC), and with higher white-matter integrity within frontolimbic circuitry. Spectroscopy and functional findings were more heterogeneous in cross-sectional designs. Only a minority of studies directly related imaging to clinical response, converging on increased amygdala-PFC/ACC connectivity, hippocampal integrity, and hippocampal, amygdalar, PFC, and ACC volumes. Overall risk of bias was substantial, yielding low-to-moderate certainty of evidence. DISCUSSION: Findings support the hypothesis that lithium's therapeutic effects may be mediated by modification of the frontolimbic circuitry, while underscoring the need for preregistration, rigorous confounding control, standardized imaging pipelines, and longer follow up to capture duration-dependent effects. Ultra-high field lithium MR imaging and imaging transcriptomics may enable the development of connectomic biomarkers predictive of clinical response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.